Xue Tao

Efgartigimod for Guillain-Barré syndrome: rationale, clinical evidence, and future perspectives

Guillain-Barré syndrome (GBS) is an acute immune-mediated peripheral neuropathy characterized by rapidly progressive symmetric limb weakness and diminished tendon reflexes, which may be complicated by respiratory muscle paralysis in severe cases. Current first-line treatments primarily consist of intravenous immunoglob...